Earnings Call · Q4 FY2024·2025-03-06

Q4 24EPS +27.88%·Rev n/aQ3 24EPS -5.88%·Rev n/aQ2 24EPS +10.53%·Rev n/aQ1 24EPS 0.00%·Rev n/a⚠ consensus missing

LEXICON PHARMACEUTICALS, INC. LXRX

Lisa DeFrancesco — Likely Investor Relations or Conference Call Moderator

Mike Exton — Chief Executive Officer and Director

Scott Chianti — Senior Vice President, likely Finance or CFO

+6.6%1d on move date+6.0% vs SPY3d−2.5%5d−2.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LXRX calls or request research access.

More LXRX calls Browse calls Request research access